Literature DB >> 29034439

Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate culture.

Uday C Ghoshal1, Chalamalasetty Sreenivasa Baba2, Ujjala Ghoshal3, George Alexander2, Asha Misra2, Vivek A Saraswat2, Gourdas Choudhuri2.   

Abstract

BACKGROUND: Though pathogenesis of non-alcoholic steatohepatitis (NASH) is unclear, association with small intestinal bacterial overgrowth [SIBO] and fecal dysbiosis is suggested. We evaluated SIBO in NASH using quantitative jejunal aspirate culture (conventional criteria: ≥ 105 colony forming unit (CFU)/mL and newer cutoff ≥ 103 CFU/mL) and glucose hydrogen breath test.
METHODS: Thirty-eight patients with NASH (age 37.5 years, range 20-54, 9, 24% female), diagnosed by ultrasonography, alanine aminotransferase >1.5 times normal and liver biopsy (in 27/38, 71%) and exclusion of other causes and 12 constipation-predominant irritable bowel syndrome as historical controls (age 39.5-y, 26-44; 3, 25% female) without fatty liver were studied.
RESULTS: Jejunal aspirates, obtained in 35/38 patients, were sterile in 14/35 (40%) and bacteria isolated in 21 (60%) (all aerobic, in one anaerobe also; Gram positive 5, negative 13, both 3). In contrast, bacteria (two Gram negative) were isolated in 3/12 (25%) controls (odds ratio 4.5, 95% CI 1.0-19.5; p = 0.04); colony counts were higher in NASH than controls (median 380 CFU/mL, 0-200,000 vs. 0 CFU/mL, 0-1000; p = 0.02). Gram negative bacteria tended to be commoner in NASH than controls (16/35 vs. 2/12; p = 0.07). Seven out of 35 (20%) patients with NASH (≥ 105 CFU/mL in 5 and 2 other on glucose hydrogen breath test) and no control had SIBO (p = ns); low-grade SIBO (≥103 CFU/mL) was commoner in NASH than controls (14/35, 40%, vs. 1/12, 8.3%; p = 0.04). There was no correlation between bacterial colony count and bacterial type and anthropometric and biochemical parameters.
CONCLUSION: Low-grade bacterial overgrowth, particularly with Gram negative bacteria, was commoner in NASH than controls.

Entities:  

Keywords:  Fatty liver; Gut microbiota; Hydrogen breath tests; Metabolic disorder; Pathogenesis

Mesh:

Substances:

Year:  2017        PMID: 29034439     DOI: 10.1007/s12664-017-0797-6

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  45 in total

1.  Liver fibrosis in overweight patients.

Authors:  V Ratziu; P Giral; F Charlotte; E Bruckert; V Thibault; I Theodorou; L Khalil; G Turpin; P Opolon; T Poynard
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

2.  Malabsorption syndrome with and without small intestinal bacterial overgrowth: a study on upper-gut aspirate using 1H NMR spectroscopy.

Authors:  Lakshmi Bala; Uday Chand Ghoshal; Ujjala Ghoshal; Pratima Tripathi; Asha Misra; G A Nagana Gowda; C L Khetrapal
Journal:  Magn Reson Med       Date:  2006-10       Impact factor: 4.668

3.  Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease.

Authors:  Venkatanarayana Gangarapu; Ali Tüzün Ince; Birol Baysal; Yusuf Kayar; Ulkan Kılıç; Özlem Gök; Ömer Uysal; Hakan Şenturk
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-07       Impact factor: 2.566

4.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  P Angulo; J C Keach; K P Batts; K D Lindor
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

5.  Jejunoileal bypass for morbid obesity. Late follow-up in 100 cases.

Authors:  M P Hocking; M C Duerson; J P O'Leary; E R Woodward
Journal:  N Engl J Med       Date:  1983-04-28       Impact factor: 91.245

6.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

7.  High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis.

Authors:  Jean-Marc Sabaté; Pauline Jouët; Florence Harnois; Charlotte Mechler; Simon Msika; Maggy Grossin; Benoît Coffin
Journal:  Obes Surg       Date:  2008-02-20       Impact factor: 4.129

8.  Frequency and factors associated with small intestinal bacterial overgrowth in patients with cirrhosis of the liver and extra hepatic portal venous obstruction.

Authors:  C P Lakshmi; Uday C Ghoshal; Sunil Kumar; Amit Goel; Asha Misra; Samir Mohindra; G Choudhuri
Journal:  Dig Dis Sci       Date:  2009-05-08       Impact factor: 3.199

9.  Implication of gut microbiota in nonalcoholic fatty liver disease.

Authors:  Jerome Boursier; Anna Mae Diehl
Journal:  PLoS Pathog       Date:  2015-01-27       Impact factor: 6.823

10.  Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease.

Authors:  Weiwei Jiang; Na Wu; Xuemei Wang; Yujing Chi; Yuanyuan Zhang; Xinyun Qiu; Ying Hu; Jing Li; Yulan Liu
Journal:  Sci Rep       Date:  2015-02-03       Impact factor: 4.379

View more
  14 in total

Review 1.  Role and effective therapeutic target of gut microbiota in NAFLD/NASH.

Authors:  Qun Liu; Shousheng Liu; Lizhen Chen; Zhenzhen Zhao; Shuixian Du; Quanjiang Dong; Yongning Xin; Shiying Xuan
Journal:  Exp Ther Med       Date:  2019-07-17       Impact factor: 2.447

2.  Small intestinal bacterial overgrowth in patients with inflammatory bowel disease: A case-control study.

Authors:  Uday C Ghoshal; Ankur Yadav; Bushra Fatima; Anand Prakash Agrahari; Asha Misra
Journal:  Indian J Gastroenterol       Date:  2021-08-14

3.  Association between acute pancreatitis and small intestinal bacterial overgrowth assessed by hydrogen breath test.

Authors:  Mei Zhang; Hong-Ming Zhu; Fang He; Bang-Yi Li; Xiao-Cui Li
Journal:  World J Gastroenterol       Date:  2017-12-28       Impact factor: 5.742

Review 4.  The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders.

Authors:  Giuseppe Losurdo; Fulvio Salvatore D'Abramo; Giuseppe Indellicati; Chiara Lillo; Enzo Ierardi; Alfredo Di Leo
Journal:  Int J Mol Sci       Date:  2020-05-16       Impact factor: 5.923

Review 5.  Pharmabiotic Manipulation of the Microbiota in Gastrointestinal Disorders: A Clinical Perspective.

Authors:  Fanny Giron; Eamonn M M Quigley
Journal:  J Neurogastroenterol Motil       Date:  2018-07-30       Impact factor: 4.924

Review 6.  What makes non-cirrhotic portal hypertension a common disease in India? Analysis for environmental factors.

Authors:  Ashish Goel; Banumathi Ramakrishna; Uday Zachariah; K G Sajith; Deepak K Burad; Thomas A Kodiatte; Shyamkumar N Keshava; K A Balasubramanian; Elwyn Elias; C E Eapen
Journal:  Indian J Med Res       Date:  2019-04       Impact factor: 2.375

7.  Patients with Specific Gastrointestinal Motility Disorders are Commonly Diagnosed as Functional GI Disorders in the Early Stage by Community Physicians due to Lack of Awareness.

Authors:  Uday C Ghoshal; Bhavesh Bhut; Asha Misra
Journal:  Turk J Gastroenterol       Date:  2021-04       Impact factor: 1.852

8.  Does colectomy predispose to small intestinal bacterial (SIBO) and fungal overgrowth (SIFO)?

Authors:  Satish S C Rao; George Tan; Hamza Abdulla; Siegfried Yu; Sebastian Larion; Pornchai Leelasinjaroen
Journal:  Clin Transl Gastroenterol       Date:  2018-04-25       Impact factor: 4.488

9.  Association between small intestinal bacterial overgrowth and beta-cell function of type 2 diabetes.

Authors:  Li-Hui Yan; Biao Mu; Da Pan; Ya-Nan Shi; Ji-Hong Yuan; Yue Guan; Wang Li; Xiao-Yi Zhu; Lei Guo
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

10.  The effectiveness of rotating versus single course antibiotics for small intestinal bacterial overgrowth.

Authors:  Nicolas Richard; Charlotte Desprez; Fabien Wuestenberghs; Anne-Marie Leroi; Guillaume Gourcerol; Chloé Melchior
Journal:  United European Gastroenterol J       Date:  2021-07-09       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.